Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer
NCT02843607Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of haploidentical natural killer cell therapy in metastatic renal cell carcinoma (mRCC), sponsored by Fuda Cancer Hospital. Started Jul 2016; status: completed.
02
Drugs
haploidentical natural killer cell therapy
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT02843607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02843607.